Last Updated: October 15, 2025
This Privacy Policy explains how MedDRA AI, Inc. (“MedDRA AI,” “we,” “us,” “our”) collects, uses, shares, and protects personal information in connection with the MedDRA AI pharmacovigilance platform, websites, voice channels, APIs, and related services (collectively, the “Services”). Your use of the Services is also subject to our Terms of Service.
1. Purpose and Scope
We process personal information (a) as a controller when we determine why and how data is processed (for example, for account management, product analytics, or marketing), and (b) as a processor or HIPAA Business Associate when we handle protected health information (PHI) on behalf of our enterprise customers. When we act as a processor, our customers are responsible for providing privacy notices to individuals and honoring their rights. This policy describes our controller activities and the support we provide to customers for processor activities.
2. Contact Information
- Privacy inquiries: privacy@meddra.co
- HIPAA privacy officer: hipaa-privacy@meddra.co
- Security incidents: security@meddra.co
- Data Protection Officer (EU/UK): dpo@meddra.co
- Mailing address: MedDRA AI, Inc., 638 College Ave, Palo Alto, CA 94306, United States.
We will publish EU/UK representative details prior to launching services in those regions.
3. Information We Collect
The information we collect depends on how you and your organization use the Services.
3.1 Account and Contact Information
- Names, titles, organization affiliations.
- Business contact details (email, phone, mailing address).
- Authentication credentials (hashed passwords, passkey metadata, MFA tokens).
- Billing contacts, subscription tier, invoicing addresses.
3.2 Platform Usage and Device Information
- Log files (IP address, device identifiers, browser type, timestamps, referrers).
- Session activity, feature usage, configuration changes.
- Telemetry and diagnostic data tied to user or pseudonymous IDs.
- Cookie identifiers and analytics tags (see Section 10).
3.3 Adverse Event and Safety Case Data
- Structured pharmacovigilance fields (patient demographics, products, events, outcomes).
- Narratives, attachments, laboratory reports, regulatory correspondence.
- Voice recordings, transcripts, SMS/email content, call metadata.
- Medical history, treatment details, reporter data, PHI, and personal data.
3.4 Support and Communications
- Support tickets, chat logs, onboarding notes, call recordings.
- Feedback, surveys, beta program responses, event participation.
- Marketing preferences and communications.
3.5 Payment and Commercial Information
- Transaction history, purchase orders, tax IDs.
- Limited payment card details processed via PCI-compliant vendors (we do not store full card numbers).
3.6 Inference Data
- Risk scores, model confidence values, workflow recommendations.
- Quality assurance tags, audit logs, reviewer overrides.
4. How We Collect Information
- Direct submissions via forms, uploads, APIs, or support communications.
- Automated collection through cookies, SDKs, telemetry, and server logs.
- Voice and telephony providers that deliver recordings and transcripts.
- Third-party integrations (safety databases, CRMs, cloud storage) configured by Customer.
- Public or regulatory sources when Customer instructs us to import data (e.g., FAERS, EudraVigilance).
- Payment processors, analytics vendors, and other service providers that assist in delivering the Services.
5. How We Use Information
When we act as a controller, we rely on the legal bases noted below for GDPR/UK GDPR purposes and applicable HIPAA allowances under a BAA.
| Purpose | Description | Legal Basis |
|---|---|---|
| Service delivery | Provide, operate, personalize, and maintain the Services; create and manage accounts; enable integrations. | Contract performance |
| Security and integrity | Authenticate users, detect fraud, enforce policies, monitor abuse, investigate incidents. | Legitimate interests; legal obligation |
| AI and model operations | Generate insights, automate data extraction, perform quality checks, fine-tune models with de-identified or authorized data. | Legitimate interests; consent (if required); HIPAA treatment/payment/operations under BAA |
| Support and communications | Respond to support requests, send service notices, provide training and onboarding. | Contract performance |
| Analytics and product improvement | Measure usage, conduct research, improve features, benchmark reliability. | Legitimate interests |
| Marketing | Send newsletters, webinars, and product updates to business contacts who opt in or where permitted. | Consent or legitimate interests |
| Compliance and legal | Meet regulatory obligations (HIPAA, pharmacovigilance, sanctions), audit, enforce agreements. | Legal obligation; legitimate interests |
We do not use PHI for marketing without explicit authorization and never sell personal information or PHI.
6. How We Share Information
- With subprocessors and service providers that host infrastructure, provide AI/ML capabilities, telephony, analytics, support, and billing. Subprocessors sign agreements imposing confidentiality, security, and data protection obligations aligned with HIPAA, GDPR, and our BAA commitments.
- With Customers when needed to fulfill instructions (for example, delivering reports, audit logs, or integration data). Authorized Users may see activity within their organization based on role-based permissions.
- With regulators, public health authorities, or law enforcement to comply with legal obligations or protect rights. We limit disclosures to the minimum required and notify Customers when legally allowed.
- In corporate transactions such as mergers, acquisitions, or financing, provided personal information remains subject to this Policy and affected Customers receive notice.
- With consent from the individual or Customer.
We do not sell personal information or share it for cross-context behavioral advertising as defined by the California Consumer Privacy Act (CCPA/CPRA).
7. International Data Transfers
We store primary production data in the United States and may transfer personal information across borders to operate the Services. When required, we implement safeguards such as Standard Contractual Clauses, UK addenda, Data Privacy Framework participation (pending certification), and contractual and technical protections for subprocessors. Region-specific hosting may be available per Order.
8. Security
- Encryption in transit and at rest for PHI and sensitive data.
- Network segmentation, zero-trust access, security monitoring, and incident response playbooks.
- Multi-factor authentication and least-privilege access for staff, plus training and background checks where permitted.
- Secure development lifecycle, code reviews, penetration testing, and vulnerability management.
- Disaster recovery and business continuity planning.
If we identify a breach affecting personal information, we will notify affected Customers and, where required, affected individuals and regulators without undue delay, consistent with the BAA and applicable law.
9. Data Retention
- We retain personal information for the duration of the Subscription Term and renewal periods, plus up to 30 days after termination to support data export.
- We retain data longer when required by law, regulation, audit obligations, or to resolve disputes (for example, pharmacovigilance record retention timelines).
- We may store de-identified or aggregated data indefinitely, provided it cannot reasonably identify an individual or Customer.
10. Cookies and Similar Technologies
We use first- and third-party cookies, pixels, and analytics tools to maintain session security, remember preferences, measure usage, and support marketing analytics for business contacts. Where legally required, we obtain consent for non-essential cookies. Users can manage cookies via browser settings or in-product controls. We honor Global Privacy Control signals by limiting analytics and advertising cookies for browsers that send the signal. We do not respond to legacy “Do Not Track” headers.
11. AI and Automated Decision-Making
- MedDRA AI's AI features capture adverse event details, classify cases, generate narratives, and surface risk signals. Outputs are advisory; qualified personnel must review them before external use.
- We maintain model versioning, training data provenance, validation artifacts, and override logs to support audit trails.
- We conduct bias, accuracy, and drift assessments consistent with the NIST AI Risk Management Framework and FDA guidance for AI-enabled medical software.
- We use de-identified or synthetic data to improve models unless a Customer authorizes broader use of identifiable information. Customers may opt out of shared model improvements, which may limit certain features.
- We do not make solely automated decisions that produce legal or similarly significant effects without human oversight.
12. Your Rights and Choices
Rights vary by jurisdiction. We honor requests as required and support our Customers in fulfilling their obligations when we act as a processor.